Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Healthcare Biotechnology
Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP... see more

TSXV:HEM - Post Discussion

Hemostemix Inc > We're pulling strong mates, let's buy! We're onto something
View:
Post by JocetooBad on Mar 18, 2022 11:47am

We're pulling strong mates, let's buy! We're onto something

We've turned the corner on bad news, now we crush shorters!
Comment by Sextant on Mar 20, 2022 9:50am
There is not a single share shorted on Hemostemix. Check for yourself. shortdata.ca
Comment by WalterTheDawg on Mar 20, 2022 11:26am
Just gotta wait and see what the terms of settlement are and if we settled with accudata as well. If all goes well there, and we get our data returned in one piece, we can get analyzing the trial and we're off to the races. I had always hoped we would reach a settlement since Aspire's cooperation in getting the phase 2 done would be preferable to their unwilling and forced compliance. The ...more  
Comment by angeloet on Mar 23, 2022 3:39pm
completely agree. people selling at these prices are absolutely nuts!! you would have to be utterly insane to not realise what this means. Settlement. IP back, Likely Phase 3 trials coming. shapiro deal on diabetes as a total cure! Phase 2 completion means the company are able to start marketIng South east Asia NOW, which means revenues straight into your the companies coffers!! We're about to ...more  
Comment by ENEMENEMYNEMO on Mar 23, 2022 4:05pm
Seems that the settlement is all in HEMs favour. No news about this from Aspire as I'm sure they are happy to get out without getting their asses sued.  I suspect HEM agreed to drop the RICO and maybe the previously awarded costs to just get the data/key back.   My break even was .27 so I'm content!
Hemostemix Inc